Pancreatic tumor-derived exosomal miR-212-3p inhibits MHC-II by downregulating the expression of regulatory factor X-associated protein (RFXAP), which promotes the immune tolerance of DCs (Figure 2) [33]. Here, RFXAP is linked to pancreatic neoplasm.